Literature DB >> 8654825

Refined solution structure of p17, the HIV matrix protein.

S Matthews1, P Barlow, N Clark, S Kingsman, A Kingsman, I Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8654825     DOI： 10.1042/bst0230725

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  19 in total

1.  Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy.

Authors:  S D Parker; J S Wall; E Hunter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.

Authors:  Zhibin Wu; Jerry Alexandratos; Bryan Ericksen; Jacek Lubkowski; Robert C Gallo; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

3.  Calmodulin binds a highly extended HIV-1 MA protein that refolds upon its release.

Authors:  James E Taylor; John Y H Chow; Cy M Jeffries; Ann H Kwan; Anthony P Duff; William A Hamilton; Jill Trewhella
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

4.  Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein.

Authors:  Omar Haffar; Larisa Dubrovsky; Richard Lowe; Reem Berro; Fatah Kashanchi; Jeffrey Godden; Christophe Vanpouille; Jürgen Bajorath; Michael Bukrinsky
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Structural and Mechanistic Studies of the Rare Myristoylation Signal of the Feline Immunodeficiency Virus.

Authors:  Janae B Brown; Holly R Summers; Lola A Brown; Jan Marchant; Paige N Canova; Colin T O'Hern; Sophia T Abbott; Constance Nyaunu; Simon Maxwell; Talayah Johnson; Morgan B Moser; Sherimay D Ablan; Hannah Carter; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2020-05-19       Impact factor: 5.469

6.  Structure of equine infectious anemia virus matrix protein.

Authors:  Hideki Hatanaka; Oleg Iourin; Zihe Rao; Elizabeth Fry; Alan Kingsman; David I Stuart
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.

Authors:  Antonella Bugatti; Cinzia Giagulli; Chiara Urbinati; Francesca Caccuri; Paola Chiodelli; Pasqua Oreste; Simona Fiorentini; Alessandro Orro; Luciano Milanesi; Pasqualina D'Ursi; Arnaldo Caruso; Marco Rusnati
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

8.  Type D retrovirus capsid assembly and release are active events requiring ATP.

Authors:  R A Weldon; W B Parker; M Sakalian; E Hunter
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2.

Authors:  Kang Chen; Indra Bachtiar; Grzegorz Piszczek; Fadila Bouamr; Carol Carter; Nico Tjandra
Journal:  Biochemistry       Date:  2008-01-26       Impact factor: 3.162

10.  Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.

Authors:  C P Hill; D Worthylake; D P Bancroft; A M Christensen; W I Sundquist
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.